162 related articles for article (PubMed ID: 21689352)
21. Adherence to microsatellite instability testing in young-onset colorectal cancer patients.
Kessels K; Fidder HH; de Groot NL; Letteboer TG; Timmer R; van Dalen T; Consten EC; Offerhaus GJ; Siersema PD
Dis Colon Rectum; 2013 Jul; 56(7):825-33. PubMed ID: 23739188
[TBL] [Abstract][Full Text] [Related]
22. The Lynch syndromes.
Lynch HT; Lynch JF
Curr Opin Oncol; 1993 Jul; 5(4):687-96. PubMed ID: 8364086
[TBL] [Abstract][Full Text] [Related]
23. Patient and tumor characteristics may raise clinicians' awareness of familial colorectal cancer: a Norwegian population-based study.
Tranø G; Wasmuth H; Sjursen W; Vatten L
Scand J Gastroenterol; 2011 Oct; 46(10):1236-42. PubMed ID: 21679123
[TBL] [Abstract][Full Text] [Related]
24. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
26. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand.
James P; Parry S; Arnold J; Winship I
N Z Med J; 2006 Sep; 119(1242):U2168. PubMed ID: 16998569
[TBL] [Abstract][Full Text] [Related]
27. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
[TBL] [Abstract][Full Text] [Related]
28. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.
Sjöström O; Lindholm L; Tavelin B; Melin B
Fam Cancer; 2016 Oct; 15(4):543-51. PubMed ID: 26935832
[TBL] [Abstract][Full Text] [Related]
29. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
30. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
31. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
[TBL] [Abstract][Full Text] [Related]
32. Metachronous colorectal cancer risk in patients with a moderate family history.
Newton KF; Green K; Walsh S; Lalloo F; Hill J; Evans DG
Colorectal Dis; 2013 Mar; 15(3):309-16. PubMed ID: 22943508
[TBL] [Abstract][Full Text] [Related]
33. Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives.
Dekker N; Hermens RP; Nagengast FM; van Zelst-Stams WA; Hoogerbrugge N;
Colorectal Dis; 2013 Apr; 15(4):e175-85; discussion p.e185. PubMed ID: 23451840
[TBL] [Abstract][Full Text] [Related]
34. [Evaluation of outpatient management in HNPCC].
Bach K; Hüppe D; Schmiegel W; Epplen JT; Kunstmann E
Z Gastroenterol; 2005 Jul; 43(7):647-51. PubMed ID: 16001346
[TBL] [Abstract][Full Text] [Related]
35. AGA Clinical Practice Update on Young Adult-Onset Colorectal Cancer Diagnosis and Management: Expert Review.
Boardman LA; Vilar E; You YN; Samadder J
Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2415-2424. PubMed ID: 32525015
[TBL] [Abstract][Full Text] [Related]
36. [Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas].
Olschwang S; Bonaïti C; Feingold J; Frébourg T; Grandjouan S; Lasset C; Laurent-Puig P; Lecuru F; Millat B; Sobol H; Thomas G; Eisinger F
Bull Cancer; 2004 Apr; 91(4):303-15. PubMed ID: 15242312
[TBL] [Abstract][Full Text] [Related]
37. Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome.
Manders P; Spruijt L; Kets CM; Willems HW; Bodmer D; Hebeda KM; Nagtegaal ID; van Krieken JH; Ligtenberg MJ; Hoogerbrugge N
Eur J Cancer; 2011 Jun; 47(9):1407-13. PubMed ID: 21273057
[TBL] [Abstract][Full Text] [Related]
38. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
[TBL] [Abstract][Full Text] [Related]
39. Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis.
Colling R; Church DN; Carmichael J; Murphy L; East J; Risby P; Kerr R; Chetty R; Wang LM
J Clin Pathol; 2015 Dec; 68(12):1036-9. PubMed ID: 26201544
[TBL] [Abstract][Full Text] [Related]
40. Lynch syndrome: implications for the surgeon.
Scaife CL; Rodriguez-Bigas MA
Clin Colorectal Cancer; 2003 Aug; 3(2):92-8. PubMed ID: 12952564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
